Westerkirk Capital Inc.
Source: SEC Form 13F · as of Mar 2026Westerkirk Capital Inc. holds 13 biotech & pharma companies tracked by BioSniper, totaling $53.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$53.9M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 12,807 | $11.8M |
| JNJJOHNSON & JOHNSON | 38,959 | $9.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 24,487 | $6.6M |
| ZTSZoetis Inc. | 54,900 | $6.5M |
| MRKMerck & Co., Inc. | 48,400 | $5.8M |
| AZNASTRAZENECA PLC | 28,729 | $5.7M |
| ABTABBOTT LABORATORIES | 32,131 | $3.3M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 4,802 | $2.1M |
| IDXXIDEXX LABORATORIES INC /DE | 1,974 | $1.1M |
| GILDGILEAD SCIENCES, INC. | 5,186 | $723K |
| UTHRUNITED THERAPEUTICS Corp | 586 | $347K |
| WSTWest Pharmaceutical Services Inc. | 995 | $249K |
| NVONovo Nordisk A/S | 2,128 | $78K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.